ContraFect Corp

NASDAQ:CFRX  
3.48
+0.07 (+2.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

ContraFect Corp Stock, NASDAQ:CFRX

28 Wells Avenue, 3rd Floor, Yonkers, New York 10701
United States of America
Phone: +1.914.207.2300
Number of Employees: 33

Description

ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.